This episode, number 23, focuses on Nasopharynx III Induction and Concurrent Systemic Therapy. Building on Episode 22, where we established NPC as a radiation-driven disease with unique anatomy and EBV biology, and Episode 22b, where we covered target volumes, we now delve into the systemic therapy backbone, the chemotherapy decisions that determine patient outcomes. This high-yield episode highlights the unique aspects of NPC systemic therapy compared to other head and neck cancers. Specifically, it explores why induction studies that failed in the oropharynx and larynx actually work in NPC, offering crucial insights for board exams.